Renato Tavares, MD^1*, Giuseppe A. Palumbo, MD^2*, Philipp Le Coutre, MD³, Francesca Palandri, MD, PhD^4*, Haifa Kathrin Al-Ali, MD^5*, Bruno Martino, MD^6*, Anna Marina Liberati, MD^7*, Jose Grasa Ullrich, MD^8*, Massimo Breccia, MD^9*, David Brittain, MD¹⁰, Lynda Foltz, MD, FRCP¹¹, Martin Griesshammer, MD^12*, Pia Raanani, MD¹³, Vikas Gupta, MD, FRCP, FRCPath¹⁴, Pilar Giraldo, MD, PhD¹⁵, Jagannath Ghosh^16*, Bayane Tannir^17*, Julian Perez Ronco, MD, MBA^17* and Alessandro M. Vannucchi, MD¹⁸

¹Universidade Federal de Goiania, Goias, Brazil
²Division of Hematology, Ospedale Ferrarotto, University of Catania, Catania, Italy
³Charité - Universitätsmedizin Berlin, Berlin, Germany
⁴University of Bologna, Bologna, Italy
⁵University of Leipzig, Leipzig, Germany
⁶Az.Osp. Bianchi-Melacrino’-Morelli, Reggio Calabria, Italy
⁷SC Oncoematologia, Azienda Ospedaliera S. Maria, Terni, Italy
⁸Unidad de Hematología, Laboratorio Doctor Grasa, Zaragoza, Spain
⁹Dipartimento di Ematologia e Biotecnologie, Universitŕ La Sapienza, Rome, Italy
¹⁰Albert Alberts Stem Transplantation Unit, Pretoria East Hospital, Pretoria, South Africa
¹¹St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada
¹²Department of Hematology and Oncology, Johannes-Wesling Clinic Minden, Minden, Germany
¹³Rabin Medical Center, Petah Tikva, Israel
¹⁴Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹⁵Miguel Servet University Hospital and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Zaragoza, Spain
¹⁶Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹⁷Novartis Pharma AG, Basel, Switzerland
¹⁸University of Florence, Florence, Italy

Srdan Verstovsek, MD¹, Moshe Talpaz, MD², Ellen Ritchie, MD³, Martha Wadleigh, MD⁴, Olatoyosi Odenike, MD⁵, Catriona Jamieson, MD, PhD⁶, Brady Stein, MD⁷, Tomonori Uno, PhD^8* and Ruben A. Mesa⁹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
³medicine and a member of the Leukemia Program, Cornell University, New York, NY
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁵University of Chicago Medical Center, Chicago, IL
⁶Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA
⁷Dept. of Medicine, Division of Hematology/Oncology and Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
⁸NS Pharma, Inc., Paramus, NJ
⁹Mayo Clinic, Scottsdale, AZ

Ayalew Tefferi, MD¹, Paola Guglielmelli, PhD MD^2*, Terra L. Lasho, PhD^3*, Yoseph Elala, MD^4*, Tiziana Fanelli, MSc^5*, Naseema Gangat, MBBS³, Christy Finke, BS^6*, Giada Rotunno, MSc^5*, Curtis A. Hanson, MD⁷, Rhett P. Ketterling, MD^8*, Animesh Pardanani, MBBS, PhD⁹ and Alessandro M. Vannucchi, MD¹⁰

¹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
²CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative,Department of Experimental and Clinical Medicine, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester
⁵CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
⁶Hematology, Mayo Clinic, Rochester, MN
⁷Division of Hematopathology, Mayo Clinic, Rochester, MN
⁸Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁹Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
¹⁰University of Florence, Florence, Italy

Animesh Pardanani, MBBS, PhD¹, Kaaren Reichard, MD², Darci Zblewski, CNP^3*, Ramy Abdelrahman, M.B., B.Ch.^3*, Emnet Wassie, M.D.^3*, William G. Morice, MD, PhD^4*, Christopher L. Brooks, PhD⁵, Curtis A. Hanson, MD⁶, Ayalew Tefferi, MD³ and Dong Chen, MD, PhD⁷

¹Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
²Laboratory Medicine and Pathology, Hematopathology Laboratory, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁵Stemline Therapeutics, Inc., New York, NY
⁶Division of Hematopathology, Mayo Clinic, Rochester, MN
⁷Division of Hematopathology, Special Coagulation Laboratory, Mayo Clinic, Rochester, MN

Lisa Pieri, MD, PhD^1,2*, Chiara Paoli, BS^1,2*, Umberto Arena, MD^3*, Fabio Marra, MD^4*, Fabio Mori, MD^5*, Mery Zucchini, MD^5*, Stefano Colagrande, MD^6*, Alessandro Castellani, MD^6*, Arianna Masciulli, PhD, MSc^7*, Vittorio Rosti, MD⁸, Valerio De Stefano, MD^9*, Silvia Betti, MD^10*, Guido Finazzi, MD^11*, Maria Luisa Ferrari, BSc^11*, Elisa Rumi, MD^12*, Marco Ruggeri, MD¹³, Ilaria Nichele, MD^13*, Paola Guglielmelli, MD, PhD^1,2*, Rajmonda Fjerza, MD^1,2*, Carmela Mannarelli, MSc^1*, Tiziana Fanelli, MSc^1,2*, Lucia Merli, BSN^1,2*, Margherita Massa, PhD^14*, Giuseppe Cimino, MD^15*, Alessandro Rambaldi, MD¹¹, Giovanni Barosi, MD⁸, Mario Cazzola, MD¹², Tiziano Barbui, MD^16* and Alessandro M. Vannucchi, MD^1,2

¹CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
²Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
³Internal Medicine and Hepatology,, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
⁴Department of Experimental and Clinical Medicine,, University of Florence, Florence, Italy
⁵Department of Cardiology, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
⁶Radiodiagnostica 2, Dip Scienze Biomediche Sperimentali e Cliniche, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
⁷Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
⁸Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
⁹Hematology, Catholic University, Rome, Italy
¹⁰Institute of Hematology, Catholic University, Rome, Italy
¹¹Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy
¹²Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹³Department of Hematology, San Bortolo Hospital, Vicenza, Italy
¹⁴Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
¹⁵S.M. Goretti, UOC Hematology, Latina, Italy
¹⁶Hospital Papa Giovanni XXIII and Research Foundation, Bergamo, Italy

Jean-Jacques Kiladjian¹, Tamás Masszi, MD, PhD², Mark M. Jones, MD^3*, Brian Gadbaw, MD⁴, Jingjin Li, PhD^4*, Dany Habr, MD^4*, Alessandro M. Vannucchi, MD⁵ and Srdan Verstovsek, MD, PhD⁶

¹Hôpital Saint-Louis and Paris Diderot University, Paris, France
²St. István and St. László Hospital, Budapest, Hungary
³Incyte Corporation, Wilmington, DE
⁴Novartis Pharmaceuticals Corporation, East Hanover, NJ
⁵University of Florence, Florence, Italy
⁶Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

A Kamel Abou Hussein, MD¹, Naseema Gangat, MBBS², Yoseph Elala, MD^3*, Alexandra Wolanskyj, MD⁴, Curtis A. Hanson, MD¹, Rhett P. Ketterling, MD^5*, Animesh Pardanani, MBBS, PhD⁶ and Ayalew Tefferi, MD⁷

¹Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Mayo Clinic, Rochester
⁴Mayo Clinic Mayo Building West 10, Rochester, MN
⁵Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁶Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
⁷Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Samer A Srour, MB ChB, MS^1,2, Susan S Devesa, MD^3*, Lindsay M Morton, PhD³, David P Check^3*, Rochelle E Curtis, MA^3*, Martha S Linet, MD, MPH^3* and Graca M Dores, MD, MPH^1,3

¹Oklahoma City VA Health Care System, Oklahoma City, OK
²Graduate College and Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK
³Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD

Francesco Passamonti, MD^1*, Martin Griesshammer, MD^2*, Michele Cavo, MD^3*, Miklos Egyed⁴, Giulia Benevolo, MD^5*, Timothy Devos, MD PhD^6*, Jeannie Callum, MD⁷, Alessandro M. Vannucchi, MD⁸, Serdar Sivgin, MD^9*, Caroline Bensasson, PhD^10*, Mahmudul Khan, PhD^11*, Nadjat Mounedji, MD^10* and Guray Saydam, MD, Prof^12*

¹Ospedale di Circolo e Fondazione Macchi, Varese, Italy
²Department of Hematology and Oncology, Johannes-Wesling Clinic Minden, Minden, Germany
³"Serŕgnoli" Institute of Hematology, University of Bologna, Bologna, Italy
⁴Kaposi Mór Teaching Hospital, Kaposvár, Hungary
⁵Cittŕ della Salute e della Scienza di, Torino, Italy
⁶Hematology, UZ Leuven, Leuven, Belgium
⁷Sunnybrook Health Sciences Centre, Toronto, Canada
⁸University of Florence, Florence, Italy
⁹Dedeman Stem Cell Transplantation Hospital, Department of Hematology, Erciyes University, Kayseri, Turkey
¹⁰Novartis Pharma S.A.S, Rueil Malmaison, France
¹¹Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
¹²Ege University Medical Faculty, Izmir, Turkey

Damien Luque Paz, MD^1*, Aurelie Chauveau, MD^1*, Caroline Buors, MD^1*, Jean-Christophe Ianotto, MD^2*, Francoise Boyer, MD^3*, Laura Samaison, MD^4*, Claude Ferec, MD, PhD^5*, Cedric Le Marechal, MD, PhD^5*, Paul Gueguen, MD^6* and Valerie Ugo, MD, PhD^7*

¹Laboratoire Hematologie, CHU Brest, Brest, France
²Centre Hospitalier Universitaire, Brest, France
³Centre Hospitalier Universitaire, Angers, France
⁴Pathology Department, CHU Brest, Brest, France
⁵INSERM U1078, CHU Brest, Brest, France
⁶Laboratoire Genetique, CHU Brest, Brest, France
⁷Laboratoire Hematologie, CHU Angers, Angers, France

Margherita Massa, PhD^1*, Rita Campanelli, BS^2*, Gabriela Fois, BS^2*, Laura Villani, BS,^2*, Elisa Bonetti, PhD^2*, Paolo Catarsi, BS^2*, Valentina Poletto, PhD^2*, Gianluca Viarengo, MD^3*, Vittorio Rosti, MD² and Giovanni Barosi, MD²

¹Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
²Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
³Immunohaematology and Transfusion Service, IRCCS Policlinico San Matteo Foundation, Pavia, Italy

Srdan Verstovsek, MD¹, Michael R. Savona, MD², Ruben A. Mesa³, Stephen Oh, MD PhD⁴, Hua Dong, PhD^5*, Dung Thai^5* and Jason Gotlib, MD⁶

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Vanderbilt University School of Medicine, Nashville, TN
³Mayo Clinic, Scottsdale, AZ
⁴Division of Hematology, Washington University School of Medicine, St. Louis, MO
⁵Gilead Sciences, Foster City, CA
⁶School of Medicine/ Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

Alessandro Andriani, MD^1*, Roberto Latagliata, MD^2*, Michele Cedrone, MD^3*, Ambra Di Veroli, MD^4*, Cristina Santoro, MD^5*, Francesca Spirito^6*, Carla Ruscio^6*, Sabrina Crescenzi-Leonetti^7*, Raffaele Porrini, MD^8*, Jonny Di Giandomenico^9*, Nicoletta Villivŕ^1*, Antonio Spadea, MD¹⁰, Angela Rago, MD^11*, Cinzia De Gregoris^12*, Paolo Cercola^13*, Barbara Anaclerico, MD^14*, Marianna De Muro, MD^15*, Stefano Felici, MD^1*, Massimo Breccia, MD^16*, Enrico Montefusco, MD^17*, Antonino Bagnato, MD^18*, Giuseppe Cimino, MD^19*, Ignazio Majolino, MD²⁰, Maria Gabriella Mazzucconi, MD^21*, Giuliana Alimena, MD²² and Marco Montanaro, MD^23*

¹UOSA of Hematology, ASL RMA, Nuovo Regina Margherita Hospital, Rome, Italy
²Department of Hematology, University, Rome, Italy
³UOC of Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
⁴Hematology, Tor Vergata University, Rome, Italy
⁵University of Rome “Sapienza”, Department of Cellular Biotechnologies and Hematology, Rome, Italy
⁶UOC of Hematology and bone marrow transplantation, San Camillo-Forlanini Hospital, Rome, Italy
⁷UOC of Hemtology, San Giovanni Hospital, Rome, Italy
⁸Hematology, Azienda Ospedaliera Sant'Andrea, Rome, Italy
⁹UOC of Hematology and bone marrow transplantation, University of PTV, Rome, Italy
¹⁰Clinical Oncology, Istituto Regina Elena, Rome, Italy
¹¹UOC of Hematology, University, Latina, Italy
¹²UOC of Hematology, ASL VT, Viterbo, Italy
¹³ASL VT, Molecolar Laboratory, Viterbo, Italy
¹⁴Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
¹⁵Hematology, Univ. Campus Bio Medieo, Rome, Italy
¹⁶. Department of Hematology, University of Rome “La Sapienza”, Rome, Italy
¹⁷Hematology Unity, Sant'Andrea Hospital, Rome, Italy
¹⁸UOC of Hematology, San Giovanni Hospital, Rome, Italy
¹⁹S.M. Goretti, UOC Hematology, Latina, Italy
²⁰Department of Hematology, Ospedale S. Camillo, Rome, Italy
²¹Centro Regionale di Riferimento per l’Emofilia e Sindromi Correlate, Universitŕ Sapienza, Policlinico Umberto I, Rome, Italy
²²Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
²³ASL VT, UOC of Hemathology, Viterbo, Italy

Sebastian Kreil, MD, PhD^1*, Lionel Adčs, MD, PhD^2*, Martin Bommer, MD^3*, Frank Stegelmann, MD^3*, Mark E Ethell, MBBChir, MA, FRCP, FRCPath^4*, Anna Lubking, MD^5*, Peter Martin, MD^6*, Ekkehard Eigendorff, MD^7*, Wolf-Karsten Hofmann, MD¹, Nicholas C.P. Cross, PhD⁸, Andreas Hochhaus, MD⁷ and Andreas Reiter, MD^1*

¹Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany
²Hospital St Louis, Paris 7 University, Paris, France
³Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
⁴Haemato-Oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁵Department of Hematology and Vascular Disorders, Skĺne University Hospital, Lund, Sweden
⁶MVZ Tempelhof, Berlin, Germany
⁷Department of Hematology and Oncology, University Hospital Jena, Jena, Germany
⁸Wessex Regional Genetics Laboratory, University of Southampton, Salisbury, United Kingdom

Brady Stein, MD¹, Alison Moliterno, MD², Ralph V. Boccia, MD³, Ahmad B. Naim, MD^4*, Joseph A. Cordaro, PharmD, MBA^4*, Wei Peng, PhD^4*, Hao Sun, MS^4*, Shreekant V. Parasuraman, PhD⁴ and Ruben A. Mesa⁵

¹Northwestern University Feinberg School of Medicine, Chicago, IL
²Johns Hopkins University School of Medicine, Baltimore, MD
³The Center for Cancer and Blood Disorders, Bethesda, MD
⁴Incyte Corporation, Wilmington, DE
⁵Mayo Clinic Cancer Center, Scottsdale, AZ

Veronika Buxhofer-Ausch^1,2*, Michael Steurer³, Siegfried Sormann^4*, Ernst Schloegel^5*, Wolfgang Schimetta^6*, Bettina Gisslinger^7*, Reinhard Ruckser^8*, Martin Schalling, MSc^7*, Guenther A. Gastl, MD⁹ and Heinz Gisslinger, MD⁷

¹Hospital Elisabethinen, Linz, Austria
²Medical University of Vienna, Linz, Austria
³Division of Hematology and Oncology, Innsbruck University Hospital, Innsbruck, Austria
⁴Medical University of Graz, Graz, Austria
⁵Hanusch Hospital, Vienna, Austria
⁶Johannes Kepler University, Linz, Austria
⁷Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria
⁸Donauspital, Vienna, Austria
⁹Internal Medicine V, Haematology & Oncology, Innsbruck Medical University, Innsbruck, Austria

Marco Montanaro, MD^1*, Roberto Latagliata, MD^2*, Michele Cedrone, MD^3*, Ambra Di Veroli, MD^4*, Cristina Santoro, MD^5*, Francesca Spirito^6*, Carla Ruscio^6*, Sabrina Leonetti-Crescenzi^7*, Raffaele Porrini, MD^8*, Jonny Di Giandomenico^9*, Nicoletta Villivŕ^10*, Antonio Spadea, MD¹¹, Angela Rago, MD^12*, Cinzia De Gregoris^13*, Paolo Cercola^14*, Barbara Anaclerico, MD^15*, Marianna De Muro, MD^16*, Stefano Felici, MD^10*, Massimo Breccia, MD^17*, Enrico Montefusco, MD^18*, Antonino Bagnato, MD^7*, Giuseppe Cimino, MD^19*, Ignazio Majolino, Prof²⁰, Maria Gabriella Mazzucconi, MD^21*, Giuliana Alimena, MD²² and Alessandro Andriani, MD^10*

¹ASL VT, UOC of Hemathology, Viterbo, Italy
²Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University La Sapienza of Rome, Rome, Italy
³UOC of Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
⁴Hematology, Tor Vergata University, Rome, Italy
⁵University of Rome “Sapienza”, Department of Cellular Biotechnologies and Hematology, Rome, Italy
⁶UOC of Hematology and bone marrow transplantation, San Camillo-Forlanini Hospital, Rome, Italy
⁷UOC of Hematology, San Giovanni Hospital, Rome, Italy
⁸Hematology, Azienda Ospedaliera Sant'Andrea, Rome, Italy
⁹UOC of Hematology and bone marrow transplantation, University of PTV, Rome, Italy
¹⁰UOSA of Hematology, ASL RMA, Nuovo Regina Margherita Hospital, Rome, Italy
¹¹Clinical Oncology, Istituto Regina Elena, Rome, Italy
¹²UOC of Hematology, University, Latina, Italy
¹³UOC of Hematology, ASL VT, Viterbo, Italy
¹⁴ASL VT, Molecolar Laboratory, Viterbo, Italy
¹⁵Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
¹⁶Hematology, Univ. Campus Bio Medieo, Rome, Italy
¹⁷Dipartimento di Ematologia e Biotecnologie, Universitŕ La Sapienza, Rome, Italy
¹⁸Hematology Unity, Sant'Andrea Hospital, Rome, Italy
¹⁹S.M. Goretti, UOC Hematology, Latina, Italy
²⁰Azienda ospedaliera S. Camillo-Forlanini, UOC di Ematologia e Trapianto di Midollo, Rome, Italy
²¹Centro Regionale di Riferimento per l’Emofilia e Sindromi Correlate, Universitŕ Sapienza, Policlinico Umberto I, Rome, Italy
²²Department of Biotechnologies and Hematology, Sapienza University, Rome, Italy

Georg Jeryczynski, MD^1*, Juergen Thiele, MD^2*, Bettina Gisslinger^1*, Maria Theresa Krauth, MD^1*, Martin Schalling, MSc^1*, Ana-Iris Schiefer, MD^3*, Ingrid Simonitsch-Klupp, MD^3*, Leonhard Muellauer, MD^3* and Heinz Gisslinger, MD¹

¹Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria
²Institute of Pathology, University of Cologne, Cologne, Germany
³Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria

Alessandro M. Vannucchi, MD¹, Heinz Gisslinger, MD², Claire N. Harrison³, Haifa Kathrin Al-Ali, MD^4*, Ester Pungolino, MD^5*, Jean-Jacques Kiladjian⁶, Francoise Boyer-Perrard, MD^7*, Franck E. Nicolini, MD, PhD⁸, Shuyuan Mo^9*, Edric Atienza, MSHS^9*, Prashanth Gopalakrishna, MBBS, MRCS^10* and Peter A. te Boekhorst^11*

¹University of Florence, Florence, Italy
²Medical University of Vienna, Vienna, Austria
³Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom
⁴University of Leipzig, Leipzig, Germany
⁵Niguarda Cŕ Granda Hospital, Milan, Italy
⁶Hôpital Saint-Louis and Paris Diderot University, Paris, France
⁷Centre Hospitalier Universitaire d'Angers, Angers, France
⁸Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁹Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹⁰Novartis Pharma AG, Basel, Switzerland
¹¹Erasmus MC/Centrumlocatie, Rotterdam, Netherlands

Krisstina L. Gowin, DO^1*, Tania Jain, MD¹, Heidi E. Kosiorek, MS^2*, John Camoriano, MD¹, Raoul Tibes, MD¹, Jeanne Palmer, MD^1* and Ruben A. Mesa²

¹Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
²Mayo Clinic, Scottsdale, AZ

Animesh Pardanani, MBBS, PhD¹, Yoseph Elala, MD^2*, Rong He, MD³, Curtis A. Hanson, MD⁴ and Ayalew Tefferi, MD⁵

¹Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
²Mayo Clinic, Rochester
³Division of Hematopathology, Special Coagulation Laboratory, Mayo Clinic, Rochester, MN
⁴Division of Hematopathology, Mayo Clinic, Rochester, MN
⁵Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Hafsa M Chaudhry, BA^1*, Kenneth W Merrell, MD^2*, Ayalew Tefferi, MD³ and Michelle A Neben Wittich, MD^2*

¹Mayo Medical School, Rochester, MN
²Mayo Clinic, Department of Radiation Oncology, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN

Michele Cedrone, MD^1*, Barbara Anaclerico, MD^2*, Francesca Paoloni, Dr^3*, Roberto Latagliata, MD^4*, Marco Montanaro, MD^5*, Francesca Spirito^6*, Sabrina Leonetti Crescenzi, MD^7*, Antonio Spadea, MD⁸, Raffaele Porrini, MD^9*, Angela Rago, MD^10*, Massimo Breccia, MD^11*, Cinzia De Gregoris^12*, Giuseppe Cimino, MD^13*, Enrico Montefusco, MD^14*, Agostino Tafuri, MD¹⁵, Giuseppe Avvisati, MD¹⁶, Ignazio Majolino, MD¹⁷, Francesco Lo Coco, MD^18*, Cristina Santoro, MD^19*, Maria Gabriella Mazzucconi, MD^20*, Carla Ruscio^6*, Marianna De Muro, MD^21*, Giuliana Alimena, MD²², Alessandro Andriani, MD^23*, Antonino Bagnato^24* and Luciana Annino^25*

¹UOC of Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
²Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
³GIMEMA, Rome, Italy
⁴Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University La Sapienza of Rome, Rome, Italy
⁵ASL VT, UOC of Hemathology, Viterbo, Italy
⁶UOC of Hematology and bone marrow transplantation, San Camillo-Forlanini Hospital, Rome, Italy
⁷UOC Haematology, San Giovanni - Addolorata Hospital, Rome, Italy
⁸Clinical Oncology, Istituto Regina Elena, Rome, Italy
⁹Hematology, Azienda Ospedaliera Sant'Andrea, Rome, Italy
¹⁰UOC of Hematology, University, Latina, Italy
¹¹Dipartimento di Ematologia e Biotecnologie, Universitŕ La Sapienza, Rome, Italy
¹²UOC of Hematology, ASL VT, Viterbo, Italy
¹³S.M. Goretti, UOC Hematology, Latina, Italy
¹⁴Hematology Unity, Sant'Andrea Hospital, Rome, Italy
¹⁵Hematology, Sapienza AO Sant'Andrea, Rome, Italy
¹⁶Dept. of Hematology, University Campus Bio-Medico, Rome, Italy
¹⁷Ematologia, Ospedale S. Camillo, Rome, Italy
¹⁸Hematology, University Tor Vergata, Rome, Italy
¹⁹University of Rome “Sapienza”, Department of Cellular Biotechnologies and Hematology, Rome, Italy
²⁰Centro Regionale di Riferimento per l’Emofilia e Sindromi Correlate, Universitŕ Sapienza, Policlinico Umberto I, Rome, Italy
²¹Hematology, Univ. Campus Bio Medieo, Rome, Italy
²²Department of Biotechnologies and Hematology, Sapienza University, Rome, Italy
²³UOSA of Hematology, ASL RMA, Nuovo Regina Margherita Hospital, Rome, Italy
²⁴UOC Haematology, San Giovanni Hospital, Rome, Italy
²⁵S.Giovanni-Addolorata Hospital, Rome, Italy

Yin Xu, MD, PhD, Brian Kwok, MD, Aine Yung, MD, Rachel Flamholz, MD, Zhao Wu, MD, PhD, Bashar Dabbas, MD and Prashanti Reddy, MD

Genoptix, Inc., a Novartis company, Carlsbad, CA

Mario Ojeda-Uribe, MD^1*, Constantin Ungureanu, MD^2*, Olivier Morel, MD^2*, Christophe Desterke, PhD^3*, Marie-Caroline Le Bousse-Kerdiles, PhD^4,5 and Hatem Boulahdour, MD, PhD^6*

¹Hematology and Cellular Therapy Unit, GHRMSA, Hôpital E Muller, Mulhouse, France
²Pôle d'Imagérie, Centre Hospitalier Universitaire de Besancon, Besancon, France
³U1197, INSERM, Hôpital Paul Brousse & Université Paris 11, VIllejuif, France
⁴Paris 11 University, Inserm U1197, Villejuif, France
⁵French Group of Myeloproliferative Disorders (FIM), Paris, France
⁶Pôle d'Imagérie, 4EA 4662-Nanomedicine Lab, Imagery and Therapeutics, Centre Hospitalier Universitaire de Besancon, Besancon, France